Application of radionuclide myocardial perfusion imaging in patients with chronic kidney disease
10.3760/cma.j.issn.2095-2848.2020.02.011
- VernacularTitle:核素心肌灌注显像在慢性肾病中的应用
- Author:
Momo SUN
1
;
Jie SHEN
Author Information
1. 天津市第一中心医院核医学科 300192
- Keywords:
Nephrosis;
Chronic disease;
Myocardial perfusion imaging;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2020;40(2):108-112
- CountryChina
- Language:Chinese
-
Abstract:
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) or even those after renal transplantation.Radionuclide myocardial perfusion imaging (MPI) is an available way to predict cardiac events and make risk stratification for CKD patients with cardiovascular diseases.Early detection and individualized treatment of patients with high-risk of cardiac events by MPI can prevent myocardial infarction and heart failure,thus improving the survival rate of this population.This article reviews the application of MPI in patients with CKD.
